SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-22-038886
Filing Date
2022-03-28
Accepted
2022-03-28 17:22:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2210477d2_sc13d.htm SC 13D 52791
  Complete submission text file 0001104659-22-038886.txt   54010
Mailing Address 750 LEXINGTON AVE 20TH FL NEW YORK NY 10022
Business Address
BENTSUR RON (Filed by) CIK: 0001251213 (see all company filings)

Type: SC 13D

Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Subject) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93555 | Film No.: 22776454
SIC: 2834 Pharmaceutical Preparations